000			01771 a2200505 4500
005			20250518042632.0
264		0	_c20200519
008			202005s 0 0 eng d
022			_a1873-5835
024	7		_a10.1016/j.leukres.2019.05.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aVasconcelos, Flavia C
245	0	0	_aAge, gender and efflux transporter activity influence imatinib efficacy in chronic myeloid leukemia patients. _h[electronic resource]
260			_bLeukemia research _c07 2019
300			_a33-35 p. _bdigital
500			_aPublication Type: Letter; Research Support, Non-U.S. Gov't
650	0	4	_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAntineoplastic Agents _xmetabolism
650	0	4	_aB-Lymphocytes _xdrug effects
650	0	4	_aBiological Transport
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate _xmetabolism
650	0	4	_aK562 Cells
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrimary Cell Culture
650	0	4	_aProgesterone _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-abl _xgenetics
650	0	4	_aSex Factors
650	0	4	_aTreatment Outcome
700	1		_aBonecker, Simone T
700	1		_ade Souza, Paloma S
700	1		_aScheiner, Marcos Antonio Mauricio
700	1		_aAmaral, Natalia
700	1		_aZalcberg, Ilana
700	1		_aThuler, Luiz Claudio S
700	1		_aMaia, Raquel C
773	0		_tLeukemia research _gvol. 82 _gp. 33-35
856	4	0	_uhttps://doi.org/10.1016/j.leukres.2019.05.012 _zAvailable from publisher's website
999			_c29753326 _d29753326